TrialOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2020

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.

M R McClung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.